The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Open accessAbstract
Pathogenic H7N9 avian influenza viruses continue to represent a public health concern, and several candidate vaccines are currently being developed. It is vital to assess if protective antibodies are induced following vaccination and to characterize the diversity of epitopes targeted. Here we characterized the binding and functional properties of twelve H7-reactive human antibodies induced by a candidate A/Anhui/1/2013 (H7N9) vaccine. Both neutralizing and non-neutralizing antibodies protected mice in vivo during passive transfer challenge experiments. Mapping the H7 hemagglutinin antigenic sites by generating escape mutant variants against the neutralizing antibodies identified unique epitopes on the head and stalk domains. Further, the broadly cross-reactive non-neutralizing antibodies generated in this study were protective through Fc-mediated effector cell recruitment. These findings reveal important properties of vaccine-induced antibodies and provide a better understanding of the human monoclonal antibody response to influenza in the context of vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“indeed partial or non-neutralizing antibodies may confer protection (Henry Dunand et al., 2016).”
From Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (2021) · cites this paper as Henry Dunand et al., 2016
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026
Self-citationHighly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 820
Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Self-citationDiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Self-citationSafety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698
Self-citationChen, H., Yuan, H., Gao, R., Zhang, J., Wang, D., Xiong, Y., Fan, G., Yang, F., Li, X., Zhou, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60111-2 · Cited by 648
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592
Self-citationRapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
Smith, K., Garman, L., Wrammert, J., Zheng, N., Capra, J. D., Ahmed, R., & Wilson, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.3 · Cited by 467
Self-citationA robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Ackerman, M. E., Moldt, B., Wyatt, R. T., Dugast, A., McAndrew, E. G., Tsoukas, S., Jost, S., Berger, C. T., Sciaranghella, G., Liu, Q., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.016 · Cited by 448
Couch, R. B., & Kasel, J. A. (1983) · Annual Review of Microbiology · doi:10.1146/annurev.mi.37.100183.002525 · Cited by 426
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
DiLillo, D. J., Palese, P., Wilson, P. C., & Ravetch, J. V. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84428 · Cited by 410
Self-citationCharacterization of H7N9 influenza A viruses isolated from humans
Watanabe, T., Kiso, M., Fukuyama, S., Nakajima, N., Imai, M., Yamada, S., Murakami, S., Yamayoshi, S., Iwatsuki‐Horimoto, K., Sakoda, Y., et al. (2013) · Nature · doi:10.1038/nature12392 · Cited by 399
Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393
Self-citationInfluenza virus hemagglutinin stalk-based antibodies and vaccines
Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 327
Self-citationRapid development of broadly influenza neutralizing antibodies through redundant mutations
Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N. L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B. M., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. (2014) · Nature · doi:10.1038/nature13764 · Cited by 290
Signal transduction during Fc receptor-mediated phagocytosis
García-García, E., & Rosales, C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1092 · Cited by 249
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Overdijk, M. B., Verploegen, S. A. B. W., Buijsse, A. O., Vink, T., Leusen, J. H. W., Bleeker, W. K., & Parren, P. W. H. I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200356 · Cited by 232
Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., Rose, R. D., Winnall, W. R., Stratov, I., Brööks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215
Jegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 184
A common solution to group 2 influenza virus neutralization
Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M. A. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 180
Margine, I., Palese, P., & Krammer, F. (2013) · Journal of Visualized Experiments · doi:10.3791/51112 · Cited by 169
Self-citationA Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum EfficacyIn Vivo
Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161
Self-citationTools to therapeutically harness the human antibody response
Wilson, P. C., & Andrews, S. F. (2012) · Nature reviews. Immunology · doi:10.1038/nri3285 · Cited by 149
Self-citationA phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Cox, R. J., Madhun, A. S., Hauge, S., Sjursen, H., Major, D., Kühne, M., Höschler, K., Saville, M. K., Vogel, F. R., Barclay, W., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.116 · Cited by 140
Mulligan, M. J., Bernstein, D. I., Winokur, P. L., Rupp, R. E., Anderson, E. J., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P. W., et al. (2014) · JAMA · doi:10.1001/jama.2014.12854 · Cited by 133
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Henry, C., Leon, P. E., Kaur, K., Tan, G. S., Zheng, N., Andrews, S., Huang, M., Qu, X., Huang, Y., Ferrer, M. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74374 · Cited by 127
Self-citationAvnir, Y., Tallarico, A. S. C., Zhu, Q. K., Bennett, A. S., Connelly, G., Sheehan, J., Sui, J., Fahmy, A., Huang, C., Cadwell, G., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004103 · Cited by 127
Tan, G. S., Lee, P. S., Hoffman, R. M. B., Mazel‐Sanchez, B., Krammer, F., Leon, P. E., Ward, A. B., Wilson, I. A., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02289-14 · Cited by 119
Self-citationEvaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
Karron, R. A., Talaat, K. R., Luke, C. J., Callahan, K. A., Thumar, B., DiLorenzo, S. C., McAuliffe, J. M., Schappell, E., Suguitan, A. L., Mills, K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.099 · Cited by 118
Self-citationA Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
Couch, R. B., Patel, S. M., Wade-Bowers, C. L., & Niño, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049704 · Cited by 116
Baudino, L., Shinohara, Y., Nimmerjahn, F., Furukawa, J., Nakata, M., Martínez-Soria, E., Petry, F., Ravetch, J. V., Nishimura, S., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6664 · Cited by 105
Talaat, K. R., Karron, R. A., Callahan, K. A., Luke, C. J., DiLorenzo, S. C., Chen, G. L., Lamirande, E. W., Jin, H., Coelingh, K. L., Murphy, B. R., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.082 · Cited by 90
Self-citationWohlbold, T. J., Chromikova, V., Tan, G. S., Meade, P. S., Amanat, F., Comella, P., Hirsh, A., & Krammer, F. (2015) · Journal of Virology · doi:10.1128/jvi.02275-15 · Cited by 81
Self-citationChen, Y., Baz, M., Lu, J., Paskel, M., Santos, C. P., Subbarao, K., Jin, H., & Matsuoka, Y. (2014) · Journal of Virology · doi:10.1128/jvi.00100-14 · Cited by 70
Self-citationBabu, T. M., Levine, M. Z., Fitzgerald, T. F., Luke, C. J., Sangster, M. Y., Jin, H., Topham, D. J., Katz, J. M., Treanor, J. J., & Subbarao, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.070 · Cited by 67
Self-citationJegaskanda, S., Laurie, K. L., Amarasena, T. H., Winnall, W. R., Kramski, M., De Rose, R., Barr, I. G., Brooks, A. G., Reading, P. C., & Kent, S. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit294 · Cited by 64
Terajima, M., Co, M. D. T., Cruz, J., & Ennis, F. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv181 · Cited by 61
Self-citationГеоргиевна, Р. Л., Kiseleva, I., Naykhin, A., Ерофеева, М. К., Stukova, M., Donina, S., Petukhova, G. D., Pisareva, M., Krivitskaya, V. Z., Grudinin, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087962 · Cited by 57
Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge
Krammer, F., Albrecht, R. A., Tan, G. S., Margine, I., Hai, R., Schmolke, M., Runstadler, J. A., Andrews, S. F., Wilson, P. C., Cox, R. J., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03095-13 · Cited by 54
Self-citationTargeting B cell responses in universal influenza vaccine design
Kaur, K., Sullivan, M., & Wilson, P. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.08.007 · Cited by 53
Self-citationHu, J., Zhu, Y., Zhao, B., Li, J., Liu, L., Gu, K., Zhang, W., Su, H., Teng, Z., Tang, S., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.25.20838 · Cited by 53
Goff, P. H., Krammer, F., Hai, R., Seibert, C. W., Margine, I., García‐Sastre, A., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.01085-13 · Cited by 52
Self-citationAn H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Krammer, F., Jul‐Larsen, Å., Margine, I., Hirsh, A., Sjursen, H., Zambon, M. C. F. A., & Cox, R. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00272-14 · Cited by 52
Self-citationSobhanie, M. M., Matsuoka, Y., Jegaskanda, S., Fitzgerald, T. F., Mallory, R. M., Chen, Y., Luke, C. J., Treanor, J. J., & Subbarao, K. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv526 · Cited by 51
Self-citationHalliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45
Self-citationSchmeisser, F., Vasudevan, A., Verma, S., Wang, W., Alvarado-Facundo, E., Weiss, C. D., Atukorale, V. N., Meseda, C. A., & Weir, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117108 · Cited by 35
Gach, J. S., Achenbach, C. J., Chromikova, V., Berzins, B., Lambert, N., Landucci, G., Forthal, D. N., Katlama, C., Jung, B. H., & Murphy, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085371 · Cited by 27
Self-citationHe, F., Prabakaran, M., Tan, Y., Kartigayen, I., Kumar, S. R., & Kwang, J. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-219 · Cited by 25
Wohlbold, T. J., Hirsh, A., & Krammer, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.026 · Cited by 15
Self-citation李鹏媛, 顾豪高, 陆家海, 吴洛林, 张定梅, 郝元涛, 徐浩, 张王剑, & 郭貔 (2015) · doi:10.3760/cma.j.issn.0254-6450.2015.05.013 · Cited by 8
Cited by
Sorted by citations
The human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 819
Self-citationAntibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572
Self-citationNatural polyreactive IgA antibodies coat the intestinal microbiota
Bunker, J. J., Erickson, S. A., Flynn, T. M., Henry, C., Koval, J., Meisel, M., Jabrì, B., Antonopoulos, D. A., Wilson, P. C., & Bendelac, A. S. (2017) · Science · doi:10.1126/science.aan6619 · Cited by 470
Self-citationReduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Supasa, P., Zhou, D., Dejnirattisai, W., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Nutalai, R., Tuekprakhon, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.033 · Cited by 460
Chen, Y.-Q., Wohlbold, T. J., Zheng, N., Huang, M., Huang, Y., Neu, K. E., Lee, J., Wan, H., Rojas, K. T., Roubidoux, E. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.030 · Cited by 419
Self-citation
Metadata
- Authors
- Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., Mullarkey, C. E., Ennis, F. A., Terajima, M., Treanor, J. J., Topham, D. J., Subbarao, K., Palese, P., Krammer, F., & Wilson, P. C.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Chicago (US)
- University of Massachusetts Chan Medical School (US)
- University of Rochester Medicine (US)
- National Institutes of Health (US)
- Corresponding author
- Krammer, Florian
- Wilson, Patrick C.
- ORCID
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 19
- Issue
- 6
- Pages
- 800-813
- ISSN
- 1931-3128 (ISSN-L)
- PMC
- PMC4901526
- OpenAlex
- W2417981936
- Cited by
- 268
- References
- 53
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 19 · 2022: 23 · 2021: 32 · 2020: 32 · 2019: 30 · 2018: 37 · 2017: 42 · 2016: 13
- FWCI
- 38.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Host & Microbe (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- World Health Organization
- National Institute of Allergy and Infectious Diseases (HHSN272201400008C), U19AI109946, P01AI097092, HHSN272200900026C, HHSN272201400005C, U19AI082724, U19AI057266, HHSN 272201400006C)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- H7N9 avian influenza, influenza vaccination, monoclonal antibodies, neutralizing antibodies, non-neutralizing antibodies, hemagglutinin epitope, hemagglutinin stalk domain, cross-reactive antibodies, vaccine-induced antibody response
- MeSH terms
- Animals, Antibodies, Monoclonal, Antibodies, Viral, Antigens, Viral, Disease Models, Animal, Dogs, Female, Humans, Influenza, Human, Influenza Vaccines, Mice, Inbred BALB C, Orthomyxoviridae Infections, Hemagglutinin Glycoproteins, Influenza Virus, Mice, Antibodies, Neutralizing, HEK293 Cells, Madin Darby Canine Kidney Cells, Influenza A Virus, H7N9 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
